President Donald Trump’s administration announced that Medicare will pay reduced prices for 15 prescription drugs, including ...

If you have either schizophrenia or psychosis you may experience symptoms like hallucinations or delusions. But although schizophrenia and psychosis have these symptoms in common, the two conditions ...

(RTTNews) - AbbVie (ABBV) announced that Alberta has added VRAYLAR® - cariprazine to its Health Drug Formulary, expanding public coverage for adults living with schizophrenia. This milestone ensures ...

Schizophrenia is a serious mental disorder involving changes in perception, thoughts, and behaviors. It typically involves a disconnection from reality, in which a person experiences hallucinations ...

AbbVie is witnessing robust growth as it moves on from its Humira patent losses. Costco is leveraging a proven business model to win even in tough consumer times. Uber's financials are looking better ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies. By Ellen Barry The Food and Drug Administration has taken a crucial step toward ...

VRAYLAR is an oral, once daily atypical antipsychotic approved as monotherapy for the treatment of schizophrenia in adults, as well as the acute management of manic, mixed, and depressive episodes ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 million upfront to form a new drug discovery pact with Gedeon Richter. Richter ...